In the US, Claforan (cefotaxime systemic) is a member of the drug class third generation cephalosporins and is used to treat Bacteremia, Bone infection, Cesarean Section, CNS Infection, Endometritis, Epiglottitis, Gonococcal Infection - Disseminated, Gonococcal Infection - Uncomplicated, Intraabdominal Infection, Joint Infection, Kidney Infections, Lyme Disease, Lyme Disease - Arthritis, Lyme Disease - Carditis, Lyme Disease - Neurologic, Meningitis, Pelvic Inflammatory Disease, Peritonitis, Pneumonia, Salmonella Gastroenteritis, Sepsis, Septicemia, Skin Infection, Surgical Prophylaxis and Urinary Tract Infection.
US matches:
- Claforan
Ingredient matches for Claforan
Cefotaxime is reported as an ingredient of Claforan in the following countries:
- Bangladesh
Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Claforan in the following countries:
- Austria
- Bahrain
- Belgium
- Brazil
- Bulgaria
- Canada
- Denmark
- Ecuador
- Ethiopia
- France
- Georgia
- Germany
- Ghana
- Greece
- Hong Kong
- Hungary
- Iceland
- India
- Indonesia
- Ireland
- Israel
- Japan
- Kenya
- Luxembourg
- Malta
- Mexico
- Netherlands
- Nigeria
- Oman
- Peru
- Russian Federation
- Singapore
- Spain
- Sweden
- Switzerland
- Taiwan
- Thailand
- United States
- Venezuela
- Vietnam
- Zimbabwe
International Drug Name Search
No comments:
Post a Comment